Shelley Griffin
Pediatrics · Waynesboro, GANPI 1336182203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $178, 2.7 times the $67 reported in 2019.
Across 58 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$153
- Abbott$94
- Boston Scientific$91
- Amgen$90
- Dexcom, Inc.$76
- AstraZeneca$59
- plus $439 from 15 others
What the payments were for
- Food & beverage$1,002100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $153 |
| Abbott | 6 | $94 |
| Boston Scientific | 3 | $91 |
| Amgen | 6 | $90 |
| Dexcom, Inc. | 5 | $76 |
| AstraZeneca | 4 | $59 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Nestle Healthcare Nutrition Inc. | 2 | $48 |
| Sanofi Pasteur Inc. | 3 | $44 |
| AbbVie | 2 | $40 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Pfizer | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Novartis | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$1,002 in reported general payments places this provider in the 80th percentile of 2,111 pediatrics providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $100 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Waynesboro
- Amir AshrafiAtlanta$563K
- Sandra ArmsteadLithonia$424K
- Satheesh ChonatAtlanta$147K
- Karen ZimowskiAtlanta$139K
- F CantrellMarietta$129K
- Iyabode Akinsanya-BeysolowAtlanta$103K
- Lauren MiddlebrooksAtlanta$71K
- Rebecca EmoryAtlanta$40K
- Mark GriffithsAtlanta$34K
- Kelly TickleAtlanta$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.